Peripheral Vascular Disease

3
Pipeline Programs
4
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
6 programs
2
Absolute Pro™ Peripheral Self-Expanding Stent SystemPhase 31 trial
Omnilink Elite™ Peripheral Balloon-Expandable Stent SystemPhase 31 trial
Angio-Seal Evolution Device RegistryN/A1 trial
IDEV SUPERA StentN/A1 trial
SUPERA® Nitinol Stent SystemN/A1 trial
+1 more programs
Active Trials
NCT00817349Completed1,004Est. Apr 2010
NCT01667393Withdrawn0Est. Jan 2013
NCT00933270Completed325Est. Jul 2014
+3 more trials
United Therapeutics
United TherapeuticsMD - Silver Spring
1 program
1
RemodulinPhase 2/31 trial
Active Trials
NCT00067041Terminated30Est. Dec 2003
Sensome
SensomeFrance - Massy
1 program
Clotild Smart Guidewire SystemN/A1 trial
Active Trials
NCT06112054Completed19Est. Aug 2024
Elutia
ElutiaSILVER SPRING, MD
1 program
CorMatrix ECM for Vascular RepairN/A1 trial
Active Trials
NCT02418156CompletedEst. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottAbsolute Pro™ Peripheral Self-Expanding Stent System
AbbottOmnilink Elite™ Peripheral Balloon-Expandable Stent System
United TherapeuticsRemodulin
SensomeClotild Smart Guidewire System
ElutiaCorMatrix ECM for Vascular Repair
AbbottIDEV SUPERA Stent
AbbottSUPERA® Nitinol Stent System
AbbottAngio-Seal Evolution Device Registry
AbbottVessel Closure

Clinical Trials (9)

Total enrollment: 1,847 patients across 9 trials

NCT00844532AbbottAbsolute Pro™ Peripheral Self-Expanding Stent System

Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.

Start: Mar 2009Est. completion: Jun 2014151 patients
Phase 3Completed
NCT01396525AbbottOmnilink Elite™ Peripheral Balloon-Expandable Stent System

Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery

Start: Mar 2009Est. completion: Jun 2014153 patients
Phase 3Completed
NCT00067041United TherapeuticsRemodulin

Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

Start: Mar 2003Est. completion: Dec 200330 patients
Phase 2/3Terminated
NCT06112054SensomeClotild Smart Guidewire System

Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection

Start: Nov 2023Est. completion: Aug 202419 patients
N/ACompleted
NCT02418156ElutiaCorMatrix ECM for Vascular Repair

A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction

Start: May 2015Est. completion: Mar 2018
N/ACompleted
NCT01667393AbbottIDEV SUPERA Stent

Popliteal Artery of Treatment With Balloon Angioplasty vs. SUPERA VERITAS Peripheral Stent System

Start: Jan 2013Est. completion: Jan 20130
N/AWithdrawn
NCT00933270AbbottSUPERA® Nitinol Stent System

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery

Start: Jul 2009Est. completion: Jul 2014325 patients
N/ACompleted
NCT00817349AbbottAngio-Seal Evolution Device Registry

Angio-Seal Evolution Device Registry

Start: Jul 2008Est. completion: Apr 20101,004 patients
N/ACompleted
NCT00736086AbbottVessel Closure

RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System

Start: Mar 2006Est. completion: Dec 2006165 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space